🔓
Sign in as a Member to unlock the full view of ENTA. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$24.50/mo already a Member? Sign in →
GovGreed
ENTA

Enanta Pharmaceuticals, Inc.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $313.7M

Small-cap specialty pharma focused on viral hepatitis and other infectious diseases with minimal direct government dependence or political engagement.

Govt Dependence
25/100
Regulatory Density
65/100
Lobbying Intensity
5/100
Political Signal
LOW

BusinessWhat ENTA does

Enanta Pharmaceuticals develops and commercializes antiviral therapeutics, primarily for hepatitis C and other infectious diseases. Revenue is driven by product sales and licensing agreements; the company has limited Medicare/Medicaid exposure relative to large-cap pharma.

Lifetime Government AwardsENTA federal contracts

ENTA doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding ENTA

$81.7M
Total ENTA held by tracked 13F funds
30
Funds with ENTA positions
+30
Funds opened this quarter
Renaissance Technologies $10M opened 2025-12-31
Renaissance Technologies $7M opened 2024-06-30
Citadel Advisors $6M opened 2024-09-30
Citadel Advisors $6M opened 2024-06-30
Renaissance Technologies $6M opened 2025-09-30
Renaissance Technologies $5M opened 2024-09-30
Two Sigma Investments $5M opened 2025-12-31
Two Sigma Investments $4M opened 2024-03-31
22 more 13F positions tracked · quarterly delta charts available in member dashboard

Congressional TradesWho in Congress is trading ENTA

2023-07-12 Daniel S. Goldman D-New York · house Sale $1,001 - $15,000
2023-07-12 Daniel S. Goldman D-New York · house sale $1,001 - $15,000
2015-05-27 (unknown) Sale $1,001 - $15,000
2015-05-27 (unknown) sale $1,001 - $15,000
2015-03-20 (unknown) Purchase $1,001 - $15,000
2015-03-20 (unknown) purchase $1,001 - $15,000
6+ trades on file · most recent 2023-08-13

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

No Form 4 activity recorded in the last 180 days.

Bills Affecting ENTALive legislation impacting this stock

Political ProfileWhere ENTA sits in Washington

Enanta has no measurable lobbying footprint, zero politician trades, and minimal campaign engagement. Stock movement is driven by clinical trial results and FDA decisions, not legislative/regulatory news.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • FDA approval delays
  • drug pricing pressure
  • patent cliff risk

Regulatory opportunities

  • orphan drug designation expansion
  • accelerated approval pathways
Member intelligence layer

Live signals + predictions for ENTA — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout ENTA & political exposure

Does Enanta Pharmaceuticals, Inc. (ENTA) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Enanta Pharmaceuticals, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded ENTA stock?
6 congressional trades by 2 unique members of Congress, most recently on 2023-07-12. See the Congressional Trading panel for politician-by-politician breakdown.
What is ENTA political risk profile?
Government dependence: 25/100. Lobbying intensity: 5/100. Political signal: low.
How does GovGreed track ENTA political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ENTA data is updated daily from these official federal sources.